Y-Intercept (HK)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.65M | Buy |
986,779
+965,328
| +4,500% | +$5.53M | 0.14% | 184 |
|
2025
Q1 | $175K | Sell |
21,451
-99,507
| -82% | -$812K | 0.01% | 1073 |
|
2024
Q4 | $1.14M | Buy |
120,958
+85,951
| +246% | +$810K | 0.08% | 375 |
|
2024
Q3 | $374K | Sell |
35,007
-68,109
| -66% | -$727K | 0.02% | 918 |
|
2024
Q2 | $1.02M | Buy |
103,116
+35,875
| +53% | +$356K | 0.06% | 483 |
|
2024
Q1 | $792K | Buy |
+67,241
| New | +$792K | 0.06% | 483 |
|
2023
Q4 | – | Sell |
-24,170
| Closed | -$294K | – | 1375 |
|
2023
Q3 | $294K | Sell |
24,170
-11,554
| -32% | -$140K | 0.03% | 781 |
|
2023
Q2 | $449K | Buy |
35,724
+20,168
| +130% | +$253K | 0.05% | 597 |
|
2023
Q1 | $173K | Sell |
15,556
-54,651
| -78% | -$606K | 0.02% | 998 |
|
2022
Q4 | $857K | Buy |
70,207
+21,708
| +45% | +$265K | 0.13% | 248 |
|
2022
Q3 | $506K | Buy |
48,499
+29,483
| +155% | +$308K | 0.05% | 535 |
|
2022
Q2 | $204K | Buy |
+19,016
| New | +$204K | 0.03% | 681 |
|
2022
Q1 | – | Sell |
-17,431
| Closed | -$201K | – | 796 |
|
2021
Q4 | $201K | Buy |
+17,431
| New | +$201K | 0.05% | 517 |
|
2021
Q3 | – | Sell |
-16,435
| Closed | -$158K | – | 734 |
|
2021
Q2 | $158K | Sell |
16,435
-45,637
| -74% | -$439K | 0.04% | 547 |
|
2021
Q1 | $583K | Buy |
62,072
+47,475
| +325% | +$446K | 0.16% | 206 |
|
2020
Q4 | $335K | Buy |
+14,597
| New | +$335K | 0.14% | 274 |
|